蜜桃传媒

Dr. Jerold Chun is professor and senior vice president of Neuroscience Drug Discovery at SBP. He completed his M.D. and Ph.D. degrees at Stanford University. He studies development and diseases of the brain.

Andrew J. Gerber, MD, PhD, is medical director and CEO of the Austen Riggs Center and an associate clinical professor in the Division of Child and Adolescent Psychiatry at Columbia University Medical Center. He is an associate clinical professor at the Child Study Center, Yale University. He is an adjunct associate professor of Psychological & Brain Sciences in the College of Natural Sciences at University of Massachusetts Amherst. He is the former co-director of the Sackler Parent-Infant Program at Columbia University, former director of the MRI Research Program at the New York State Psychiatric Institute, and former director of research at the Columbia University Center for Psychoanalytic Training and Research. While in New York, he also had a private psychoanalytic practice.

Dr. Gerber completed a PhD in psychology at the Anna Freud Centre and University College London where he studied with Peter Fonagy and Joseph Sandler, investigating the process and outcome of psychoanalysis and psychoanalytic psychotherapy in young adults. He completed his medical and psychiatric training at Harvard Medical School, Cambridge Hospital, and Weill Cornell and Columbia medical schools and his psychoanalytic training at Columbia. He trained as a research fellow with Bradley Peterson at the New York State Psychiatric Institute in brain imaging and child psychiatry. He has published and received grants in the areas of developmental psychopathology, attachment, and functional neuroimaging of dynamic processes, including social cognition and transference. He has also been involved in planning and teaching psychoanalytic research as head of the Science Department at the American Psychoanalytic Association and chair of the Committee on Scientific Activities, secretary of the Psychoanalytic Psychodynamic Research Society, and a member of the psychotherapy research committees of the American Academy of Child and Adolescent Psychiatry.

Dr. Gerber is married to Andrea Gerber, PhD, who is a clinical psychologist. They have two young daughters, Samantha and Lila.

Dr. Gerber鈥檚 published scholarship shows his deep passion for research. For a list (and downloadable copies) of Dr. Gerber's publications, see: http://www.researchgate.net/profile/Andrew_Gerber

Isaac Yang, M.D., is a nationally renowned neurosurgeon specializing in brain tumors, superior semicircular canal dehiscence (SSCD), and skull base brain surgery at UCLA. Yang is a board-certified neurosurgeon and director of medical student education for the UCLA Department of Neurosurgery; an associate professor of neurosurgery, head and neck surgery, and radiation oncology at the David Geffen School of Medicine at UCLA, and a principal investigator at the UCLA brain tumor laboratory. Yang is highly sought out by peers, patients and the media for his expertise in neurological diseases and brain health. He has made multiple TV appearances on Good Morning America, CBS' The Doctors, Dr. Drew LifeChangers, and several national news outlets. Originally from Lodi, Calif., Yang developed an interest in neurobiology as an undergraduate. He earned his bachelor’s degree with Phi Beta Kappa from the University of California, Berkeley. His training followed with a medical degree from the David Geffen School of Medicine at UCLA. Yang completed a neurological surgery residency at the University of California San Francisco, as well as an NRSA NIH-funded F32 postdoctoral brain tumor research fellowship. Yang’s clinical focus has been primarily on brain tumors, both glioblastoma and skull base tumors. His research efforts have examined antigen expression and manipulation of the immune response to glioblastoma. His work was recognized by a UCSF Clinical and Translational Scientist Training Award and the CNS Dandy Clinical Research Fellowship. Yang has been the recipient of several distinguished regional and national awards, including the UCSF Medical Center 2010 Exceptional Physician Award, the AANS Integra Brain Tumor Research Award, San Francisco Neurological Society Edwin Boldrey Award for Basic Science Research, American Academy of Neurological and Orthopedic Surgeons Research Award, Kaiser Award for Clinical Research, the national AANS Leksell Radiosurgery Award, and the Tumor Section Ronald L. Bittner Award on Brain Tumor Research. Yang has published more than 150 publications in peer-reviewed journals and authored more than half a dozen book chapters. At UCLA, he is investigating the use of nanoparticles and nanotechnology for their application in brain tumor immunotherapy and vaccines. Dr. Isaac Yang is dedicated to improving the care and treatment of all patients undergoing neurosurgery. If interested please follow Dr. Yang on Facebook at Isaac Yang UCLA Neurosurgery or find his most recent book, Service Minded Physician, on Amazon.

Dr. Lara Ray received her PhD in Clinical Psychology from the University of Colorado at Boulder. During her graduate degree she completed interdisciplinary training in behavioral genetics and neuroscience. Dr. Ray completed a predoctoral clinical internship at Brown University Medical School where she stayed for a postdoctoral fellowship at the Brown University Center for Alcohol and Addiction Studies. After her postdoctoral fellowship, Dr. Ray joined the faculty at the UCLA Clinical Psychology Program where she is now a Full Professor. Dr. Ray also has academic appointments in the UCLA Department of Psychiatry and Human Behavior and the UCLA Brain Research Institute. Dr. Ray has an active program of research on clinical neuroscience of addiction. Her laboratory combines experimental psychopharmacology with behavioral genetic and neuroimaging methods to ascertain the mechanisms underlying addictive disorders in humans and applying these insights to treatment development. Dr. Ray has over 150 peer-reviewed publications and book chapters. Her program of research is funded by the National Institute on Alcohol and Abuse and Alcoholism (NIAAA) as well as the National Institute on Drug Abuse (NIDA). Dr. Ray’s current interest centers around the clinical science informed translation of neurobiological models of addiction to clinical samples. Dr. Ray has received awards from the American Psychological Association (APA) for early career contributions to the science of addiction, including awards from the Society of Addiction Psychology (APA div 50), the Society of Clinical Psychology (APA div 12), and the Research Society for Alcoholism.

I have almost 40 years of experience in the field of alcoholism research, with much of my work focusing on the molecular sites and mechanisms of alcohol action in brain. My group has extensive experience with mouse behavioral models of alcohol consumption and dependence and was involved in some of the initial studies of the neuroimmune basis of alcohol dependence. Profiling brain gene expression is key to understanding addiction, and we were among the first to study the human brain transcriptome. We have implemented microRNA profiling and next-generation sequencing to extend our studies of molecular remodeling by alcohol in human and mouse brain. We study the genetic overlap in human alcoholics and animal models of alcohol dependence and examine the neurobiological systems involved. My research encompasses the fields of genomics, behavior, systems biology, and bioinformatics. Overall, my work has combined functional, structural, behavioral, and genomic approaches to define sites of alcohol action. Currently, I am Associate Director of the Waggoner Center for Alcohol and Addiction Research at The University of Texas at Austin and previously served as Director for 20 years. I am also the Consortium Director for the Integrative Neuroscience Initiative on Alcoholism (INIA)-Neuroimmune, where our goal is to identify and test candidate drugs that may be repurposed to treat alcohol use disorders.

 Dr. Amitai Abramovitch is an Assistant Professor at the Department of Psychology at Texas State University. Dr. Abramovitch is a Licensed Clinical Psychologist and received his MA degree in Clinical Neuropsychology from the Academic College of Tel-Aviv University and obtained his Ph.D. in Psychology from Tel-Aviv. He has extensive clinical experience in individual and couple psychotherapy, parent training, and neuropsychological assessments, both from his work in national centers, hospitals, and private practice.

Dr. Lesley Fellows is a neurologist specializing in disorders of cognition. She has a particular interest in the functions of the brain's frontal lobes. Her research program focuses on the brain basis of decision making in humans, using the tools of cognitive neuroscience. She studies how focal brain damage or neurochemical dysfunction affects all aspects of decision making, how options are generated and organized, how they are valued and compared, and how choices are made. She is also interested in more general questions about the roles of the frontal lobes in the regulation of emotion, the expression of personality traits, and the representation of past and future information. This work has relevance for understanding impaired executive function following frontal lobe injury from aneurysm rupture, stroke, or tumor growth, as well as in degenerative conditions such as Parkinson鈥檚 Disease and some forms of dementia. It also provides insights into how the component processes that underlie decision making are carried out in the intact brain.

Wayne Sossin is interested in the biochemical changes that occur in the brain during learning and memory. Of particular interest is the identification of molecular memory traces that underlie behavioural memory. Sossin's laboratory examines this problem in the simple nervous system of Aplysia, where behavioural memory is encoded by changes in the synaptic strength of identified neurons. In this system, one can visualize memory using modern imaging techniques and electrophysiology, and thus investigate the underlying molecular basis of memory. His laboratory is investigating several candidates for the molecular trace, including the activation of persistent kinases and the regulated translation of new proteins.

Philip J. Horner received a Ph.D. in physiology from Ohio State University and completed a postdoctoral fellowship at The Salk Institute for Biological Studies. Horner's research is focused on the interaction between glial and neural cells following central nervous system challenge. His area of expertise is in regenerative medicine for multiple sclerosis, neural trauma, stroke and more.

Research Summary: Professor Yates’ research focuses on the role of the vestibular system in the maintenance of homeostasis, the function of the vestibular system in spatial cognition, and plasticity within the vestibular system following damage to the inner ear. Vestibular receptors detect linear and angular acceleration imposed on the head, and thus provide signals to the central nervous system (CNS) that indicate head position and the direction and velocity of head movements. By integrating vestibular inputs with signals from receptors in the neck, trunk, and limbs, the central nervous system can differentiate head and whole-body movements and thus produce appropriate compensatory responses. Vestibular effects on respiratory motoneurons, on sympathetic neurons that regulate circulation, and on CNS neurons that mediate spatial cognition are the major concern of the laboratory. We are also interested in the mechanisms responsible for recovery of function following loss of vestibular inputs. The majority of the current research utilizes electrophysiological and neuroanatomical approaches to characterize the neuronal circuitry that relays vestibular signals to spinal motoneurons, sympathetic preganglionic neurons, and CNS regions that mediate spatial cognition. Furthermore, we are examining the effects of stimulation or lesioning the vestibular system on respiration and circulation, to gain a better understanding of the role of the vestibular system in maintaining homeostasis during movement, changes in posture, and exposure to unusual gravitational environments (such as during space travel). Other experiments are exploring the role of the vestibular system in spatial cognition as well as “sensory substitution” that explains recovery of function following vestibular system lesions. Finally, we are interested in the physiological basis of an aberrant autonomic effect that can result from vestibular stimulation: motion sickness. Education & Training Ph.D. University of Florida (1986)

What we do: We answer both applied and basic questions about how the nervous system helps animals survive in their environments. On the applied side, we study animals that evolved ways to avoid damage to the nervous system. We focus most of our efforts on challenges to the nervous system that tend to be big problems in many human diseases. These include inactivity of neuromuscular systems (think, “if you don’t use it you lose it”) and impaired oxygen transport (think, brain damage in stroke and cardiac arrest). By learning from animals that already “know” how to get around these problems, we up our chances of finding new solutions. On the basic side, we use this approach to make new discoveries about how nervous systems use plasticity to help animals adapt to their environments. To do this, we take fundamental concepts about plasticity that were developed outside of real-life contexts (e.g., cell culture, lab settings, modeling, etc.) and test how they work in situations where animals may need them to survive. This allows us to put together new ideas about how these processes are important for behavior and why they may have evolved. How we do it: We tend to ask questions using the neural system that regulates breathing in amphibians for two reasons. First, breathing is a tractable, rhythmic behavior that is easily studied across scales of organization (genes to proteins to cells to networks to behavior) compared to other behaviors like learning and memory. Second, amphibians have interesting life history traits that allow us to ask questions about how different forms of plasticity have adaptive importance in nature. On the technical side, we use an integrative approach that spans whole animal behavior down to the molecular biology of single neurons. We use a range of tools that include patch-clamp electrophysiology to study electrical properties of neurons, single-cell quantitative PCR and RNA sequencing to assess gene expression in individual neurons, in vivo measurements of behavior (measurements of breathing and EMG to record muscle activity), extracellular recording to measure circuit activity, and fluorescence imaging microscopy. Interests Cellular neuroscience, comparative neurobiology, electrophysiology Education Ph.D., Wright State University Research: What we do: We answer both applied and basic questions about how the nervous system helps animals survive in their environments. On the applied side, we study animals that evolved ways to avoid damage to the nervous system. We focus most of our efforts on challenges to the nervous system that tend to be big problems in many human diseases. These include inactivity of neuromuscular systems (think, “if you don’t use it you lose it”) and impaired oxygen transport (think, brain damage in stroke and cardiac arrest). By learning from animals that already “know” how to get around these problems, we up our chances of finding new solutions. On the basic side, we use this approach to make new discoveries about how nervous systems use plasticity to help animals adapt to their environments. To do this, we take fundamental concepts about plasticity that were developed outside of real-life contexts (e.g., cell culture, lab settings, modeling, etc.) and test how they work in situations where animals may need them to survive. This allows us to put together new ideas about how these processes are important for behavior and why they may have evolved. Recent Publications: Adams, S., Zubov, T., Bueschke, N., & Santin, J. M. Neuromodulation or energy failure? Metabolic limitations silence network output in the hypoxic amphibian brainstem. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2020. In press. doi.org/10.1152/ajpregu.00209.2020 Burton, M. T., & Santin, J.M. A direct excitatory action of lactate ions in the central respiratory network. 2020. Journal of Experimental Biology. In press. doi: 10.1242/jeb.235705 Northcutt, N.J., Kick, D.R., Otopalik, A.G., Goetz, B.M., Harris, R.M., Santin, J.M., Hoffman, H.A., Marder, E., Schulz, D.J. Molecular profiling of single neurons of known identity in two ganglia from the crab Cancer borealis. Proceedings of the National Academy of Sciences. 2019. doi: https://doi.org/10.1073/pnas.1911413116 Santin, J.M. Motor inactivity in hibernating frogs: Linking plasticity that stabilizes neuronal function to behavior in the natural environment. Developmental Neurobiology. 2019, in press doi: https://doi.org/10.1002/dneu.22721

Brett Wingeier, Ph.D., is co-founder and chief executive officer of Magnus Medical and a member of its Board of Directors. He brings over 20 years of experience in the development and commercialization of advanced neurotechnology. Most recently, he was a co-founder of Halo Neuroscience, where he was chief technology officer and later assumed the additional role of CEO. During his tenure at Halo, he raised $26 million over seven years to commercialize non-invasive electrical brain stimulation across consumer and medical applications. He was also the architect of Halo Sport, the world鈥檚 first consumer neurostimulation headset for movement training, as well as the company鈥檚 next-generation products, which remain under development for cognitive and psychiatric health. As CTO, he built and supervised hardware and software development teams, led Halo鈥檚 applied neuroscience research program, led manufacturing operations in the U.S. and Asia, and managed IP and regulatory affairs. As CEO, he additionally supervised clinical affairs, distribution, e-commerce, direct-to-consumer sales, partnerships, marketing, and customer support for Halo鈥檚 portfolio of products. 

Before co-founding Halo, Dr. Wingeier was one of the first employees at NeuroPace, where he co-developed the world鈥檚 first responsive neurostimulator for epilepsy鈥攃alled the RNS System鈥攚hich received PMA approval from the U.S. Food & Drug Administration (FDA) in 2013. At NeuroPace, he was the principal biomedical engineer responsible for firmware engineering, clinical science, biostatistics, and product management. Today, the RNS System is an accepted treatment for intractable epilepsy, with over 2,000 implants and 82% seizure frequency reduction. In parallel, he was instrumental in the development and clinical trial of Autonomic Technologies鈥� Pulsante implant, which attained CE Mark certification to treat cluster headaches in 2012, and migraine headaches in 2017. 

Dr. Wingeier received a Bachelor of Science in Biomedical Engineering and his Ph.D. in Biomedical Engineering, both from Tulane University. He has completed additional studies at Swinburne University鈥檚 Brain Science Institute and at Stanford Biodesign. Dr. Wingeier is a registered patent agent, a prolific inventor with over 60 issued U.S. patents, and a member of the IEEE Working Group on Neuroethics.

Brandon Bentzley, M.D., Ph.D., is a co-founder and chief scientific officer of Magnus Medical. His interest in neuroscience led him to begin the Medical Scientist Training Program at the Medical University of South Carolina (MUSC), which is the birthplace of clinical transcranial magnetic stimulation (TMS) for the treatment of neuropsychiatric disorders. At MUSC, he completed his dissertation research with Gary Aston-Jones, Ph.D., studying the behavioral economics and neuroeconomics of substance use disorders. Simultaneously, he conducted clinical research on buprenorphine maintenance therapy, focusing on how patient perspectives influence treatment. He completed his residency in adult psychiatry and his postdoctoral training at Stanford University, where he focused on the development of SAINT technology. Dr. Bentzley has published articles in high-impact peer-reviewed journals, including Brain, American Journal of Psychiatry, Molecular Psychiatry, Biological Psychiatry, Journal of Neuroscience, Journal of the American Medical Association Network Open, and Proceedings of the National Academy of Sciences of the United States of America.

In parallel with his clinical work, Dr. Bentzley has over 15 years of experience in developing advanced automated systems that range from plasma reactors used in variable gravity experiments at NASA, to high-powered magnetically confined plasma reactors at Princeton University. He has developed and built a highly advanced neuro-behavioral recording system, which is currently in full-time use at the Malenka Lab in the Department of Psychiatry at Stanford Medicine.

Dr. Bentzley received a Bachelor of Science in Physics from The College of New Jersey, and his M.D. and Ph.D. from MUSC. His academic appointments include Clinical Assistant Professor in Psychiatry and Behavioral Sciences at Stanford University School of Medicine. His areas of clinical focus are treatment-resistant depression, substance abuse disorders, and suicidality.

Emily Falk is a Professor of Communication, Psychology, and Marketing at the University of Pennsylvania; Director of Penn's Communication Neuroscience Lab; and a Distinguished Fellow of the Annenberg Public Policy Center. Falk is an expert in the science of behavior change. Her research uses tools from psychology, neuroscience, and communication to examine what makes messages persuasive, why and how ideas spread, and what makes people effective communicators.

Her research has been recognized by numerous awards, including early career awards from the International Communication Association, the Society for Personality and Social Psychology Attitudes Division, a Fulbright grant, the Social and Affective Neuroscience Society, a DARPA Young Faculty Award, and the NIH Director鈥檚 New Innovator Award. She was named a Rising Star by the Association for Psychological Science. She received her bachelor鈥檚 degree in Neuroscience from Brown University and her Ph.D. in Psychology from the University of California, Los Angeles.

Professor Paul Howard-Jones is based in the University of Bristol’s Graduate School of Education, where his research is focused on issues at the interface of cognitive neuroscience and educational theory, practice and policy. He applies diverse research methods from computational brain imaging studies to classroom observations in order to understand learning processes and their potential relevance to educational learning. He is particularly interested in the processes by which games and learning games engage their players and can support learning. Professor Howard-Jones was formerly a member of the UK's Royal Society working group on Neuroscience and Education (2011). In 2020 he completed a fellowship at UNESCO (Geneva) focused on the relation of neuroscience to global educational and cultural contexts, and has authored numerous reviews and one of the first text books in this area (Evolution of the Learning Brain, Routledge, 2010). He has participated in many international academic and public debates regarding the interrelation of these two diverse subject areas and is currently implementing neuroscience into Initial Teacher Education at the University of Bristol (supported by the Wellcome Trust). He is more widely known for his contributions to Channel Four’s Secret Life of Four Year Olds and other broadcasts. His second book, A Short History of the Learning Brain, has just been published by Routledge, and he has been researching teachers’ attitudes and practices around climate change education. He currently co-ordinates the UK’s Climate Change Education Network. Education PhD Medical Physics, University of Exeter Affiliations 2016 - 2020 - Senior Fellow at the International Bureau of Education (UNESCO) Accomplishments 2018 - IMBES Translation Award (International Brain Mind and Education Society)

Dr. Jeremy Nathans is a professor of molecular biology and genetics, neuroscience and ophthalmology at the Johns Hopkins University School of Medicine. His research focuses on molecular mechanisms of visual system development, function, and disease. Dr. Nathans is responsible for landmark discoveries that have changed our understanding of how humans see the world. His investigations into the mechanisms that allow us to see colors led him to identify the genes that code for color-vision receptors in the light-sensing cones of the retina. This breakthrough finding allowed him to show that variations in these genes cause color blindness. His work has also led to new understandings of the development, function and survival of the retina. Dr. Nathans received his undergraduate degree in Life Sciences and Chemistry from MIT and earned his Ph.D. in Biochemistry and M.D. from Stanford University. He completed a postdoctoral fellowship at Genentech, Inc. Dr. Nathans joined the Johns Hopkins faculty in 1988. He serves on the editorial board of Proceedings of the National Academy of Sciences and is on many scientific advisory boards including The Foundation Fighting Blindness and Merck Research Laboratories. He became a member of the Institute of Medicine in 2011 and his work has been recognized with numerous awards, including the Edward M. Scolnick Prize in Neuroscience by the McGovern Institute at the Massachusetts Institute of Technology.

Nick Allen has more than thirty years of experience in clinical psychology, social neuroscience, research and education. His research works to understand the interactions between multiple risk factors for adolescent onset mental health disorders, and to use these insights to develop innovative approaches to prevention and early intervention. As the director of the Center for Digital Mental Health, his group holds multiple NIH funded grants for work focusing on the use of mobile and wearable technology to monitor risk for poor mental health outcomes including suicide, depression, and bipolar disorder. His team has developed software tools that combine active and passive sensing methods to provide intensive longitudinal assessment of behavior with minimal participant burden. The ultimate aim of these technologies is to develop a new generation of “just-in-time” behavioral interventions for early intervention and prevention of mental health problems. He is currently leading a project with Google to determine the effect that smartphone usage has on mental health. Nick is also the co-founder and CEO of Ksana Health Inc, a company whose mission is to use research evidence and modern technology to revolutionize the delivery of mental health care through remote behavioral monitoring and adaptive, continuous behavior change support.

Dr. Grill has been the recipient of the National Alzheimer’s Coordinating Center Junior Investigator Award, the Alzheimer’s Association Turken Research Prize, the Community Spirit Award from OPICA Adult Day Services, and the P. Gene and Elaine Smith Term Chair in Alzheimer’s Disease Research. He has been funded by the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Alzheimer’s Association, the Hartford Foundation, the BrightFocus Foundation, the American Federation for Aging Research, and the University of California. He is the co-leader of the Recruitment Unit and the Internal Ethics Committee for the NIH-funded Alzheimer’s Clinical Trial Consortium. He is a member of the Scientific Advisory Board for Maria Shriver’s Women’s Alzheimer’s Movement and for Lauren Rogen Miller and Seth Rogan's HfC. In 2017, he co-chaired a workgroup as part of the NIH’s Inclusion Across the Lifespan workshop, a congressional mandate in the 21st Century Cures Act (P.L. 114-255). He was part of a working group sponsored by the National Institute on Aging and the Alzheimer’s Association charged with creating a national strategy for recruitment to Alzheimer’s disease clinical research.

Physicist Richard Taylor is internationally known for his innovation using bioinspiration to improve health and wellbeing. He has published more than 300 papers, including 11 papers Nature and 3 in Science. His work has been featured in TV documentaries and the subject of articles in The New York Times, Scientific American, The New Yorker, as well as popular science books. Taylor studies fractals in physics, psychology, physiology, geography, architecture and art. He designed bio-inspired retinal implants to restore vision to victims of retinal diseases. His other work uses bio-inspired fractal images to reduce people's stress levels in the built environment, such as in carpets. He also uses computer analysis to study and authenticate art works and is considered the leading expert on the artist Jackson Pollock.

Taylor regularly gives lectures around the world, invited by organizations as diverse as the Nobel Foundation, the White House, the Royal Society and national art galleries such as the Pompidou Centre and the Guggenheim Museum.

Angeliki Damilou is a developmental neuroscientist with a background in psychology. Angeliki obtained her MSc Diploma in Clinical Neurodevelopmental Sciences at King’s College London and currently she is finishing her PhD studies at the Brain Research Institute at the University of Zurich. Angeliki’s PhD research aims to uncover developmental mechanisms that shape the typical brain connectivity in order to identify critical periods that lead to Autism Spectrum Disorder diagnosis.